Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2000-06-15
2002-09-10
Prouty, Rebecca E. (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S320100, C435S325000, C435S252300, C435S145000
Reexamination Certificate
active
06448025
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to methods for the identification of compounds that modulate the activity of target proteins having motor domains and use of such methods for the identification of therapeutic agents.
BACKGROUND OF THE INVENTION
The kinesin superfamily is an extended family of related microtubule motor proteins. It can be classified into at least 8 subfamilies based on primary amino acid sequence, domain structure, velocity of movement, and cellular function. This family is exemplified by “true” kinesin, which was first isolated from the axoplasm of squid, where it is believed to play a role in anterograde axonal transport of vesicles and organelles (see, e.g., Goldstein,
Annu. Rev. Genet.
27:319-351 (1993)).
Mitotic kinesins are enzymes essential for assembly and function of the mitotic spindle, but are not generally part of other microtubule structures. Mitotic kinesins play essential roles during all phases of mitosis. These enzymes are “molecular motors” that translate energy released by hydrolysis of ATP into mechanical force which drives the directional movement of cellular cargoes along microtubules. The catalytic domain sufficient for this task is a compact structure of approximately 340 amino acids. During mitosis, kinesins organize microtubules into the bipolar spindle that is the mitotic spindle. Kinesins mediate movement of chromosomes along spindle microtubules, as well as structural changes in the mitotic spindle associated with specific phases of mitosis. Experimental pertubation of mitotic kinesin function causes malformation or dysfunction of the mitotic spindle, frequently resulting in cell cycle arrest.
Within this functional group of kinesins resides a group of kinesins from several organisms that share significant sequence homology. These include human MKPL1 (also known as mitotic kinase-like protein-1) (HsMKPL1),
C. elegans
M03D4.1,
C. griseus
CHO1, and
D. melanogaster
PAV-KLP.
MKPL1 is essential for proper organization of these interzonal microtubules and for subsequent formation of the contractile ring. MKLP1 localizes to microtubules of the spindle midzone throughout mitosis. In vitro, MKLP1 can slide antiparallel microtubules relative to each other. Microinjection of antibody directed against MKLP1 into mammalian cells induces mitotic arrest with subtle defects in microtubule organization.
Genetic data from both Drosophila and
C. elegans
clearly show that MKLP1 homologues are required for organization of the interzonal microtubules of the anaphase spindle and for formation of a functional contractile ring.
Defects in function of these proteins would be expected to result in cell cycle arrest in mitosis. As such, compounds that modulate the activity of these kinesins may affect cellular proliferation. The present invention provides a novel method to identify such compounds.
SUMMARY OF THE INVENTION
The present invention provides methods to identify candidate agents that bind to a target protein or act as a modulator of the binding characteristics or biological activity of a target protein. In one embodiment, the method is performed in plurality simultaneously. For example, the method can be performed at the same time on multiple assay mixtures in a multi-well screening plate. Furthermore, in a preferred embodiment, fluorescence or absorbance readouts are utilized to determine activity. Thus, in one aspect, the invention provides a high throughput screening system for detecting modulators of activity a target protein.
In one embodiment, the present invention provides a method of identifying a candidate agent as a modulator of the activity of a target protein. The method comprises adding a candidate agent to a mixture comprising a target protein which directly or indirectly produces ADP or phosphate, under conditions that normally allow the production of ADP or phosphate. The method further comprises subjecting the mixture to a reaction that uses said ADP or phosphate as a substrate under conditions that normally allow the ADP or phosphate to be utilized and determining the level of activity of the reaction as a measure of the concentration of ADP or phosphate. A change in the level between the presence and absence of the candidate agent indicates a modulator of the target protein.
The phrase “use ADP or phosphate” means that the ADP or phosphate are directly acted upon by detection reagents. In one case, the ADP, for example, can be hydrolyzed or can be phosphorylated. As another example, the phosphate can be added to another compound. As used herein, in each of these cases, ADP or phosphate is acting as a substrate.
Preferably, the target protein either directly or indirectly produces ADP or phosphate and comprises a motor domain. More preferably, the target protein comprises MKPL1,
C. elegans
M03D4.1,
C griseus
CHO1, and
D. melanogaster
PAV-KLP or a fragment thereof. Most preferably, the target protein comprises SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.
Also provided are modulators of the target protein including agents for the treatment of cellular proliferation, including cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. The agents and compositions provided herein can be used in variety of applications which include the formulation of sprays, powders, and other compositions. Also provided herein are methods of treating cellular proliferation disorders such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation, for treating disorders associated with MKLP1 activity, and for inhibiting MKLP1.
REFERENCES:
patent: 6207403 (2001-03-01), Goldstein et al.
Nislaw et al., Nature, 359,543-547, 1992, see the attached alignment.*
Schmid et al. (1998) “Sequence and expression of DmMKLP1, a homolog of the human MKLP1 kinesin-like protein from Drosophila melanogaster” Dev. Genes Evol. 208(8):474-6.
Ferhat et al. (1998) “Expression of the mitotic motor protein Eg5 in postmitotic neurons: Implications for neuronal development” J. Neurosci. 18(19):7822-35.
Powers et al. (1998) “A nematode kinesin required for cleavage furrow advancement” Curr. Biol. 8(20):1133-6.
Yu et al. (1997) “Inhibition of a mitotic motor compromises the formation of dendrite-like processes from neuroblastoma cells” J. Cell Biol. 136(3):659-68.
Sharp et al. “Identification of a microtubule-associated motor protein essential for dendritic differentiation” J. Cell Biol. (1997) 138:833-843.
Kuriyama et al. “Heterogeneity and microtubule interaction of the CHO1 antigen, a mitosis-specific kinesin-like protein” J. Cell Science (1994) 107:3485-3499.
Nislow et al. “A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles” Nature (1992) 359:543-547.
US Patent Application No. 09/314,464, Finer et al., Filed May 18, 1999, Title: Compositions and assays utilizing ADP or phosphate for detecting protein modulators.
Beraud Christophe
Vaisberg Eugeni A.
Wood Kenneth W.
Beyer Weaver & Thomas LLP
Cytokinentics, Inc.
Monshipouri Maryan
Prouty Rebecca E.
Stevens, Esq. Lauren L.
LandOfFree
Motor proteins and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Motor proteins and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Motor proteins and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2906791